Department of Medicine, University of Melbourne, Parkville, Victoria, Australia.
Department of Rheumatology, Austin Health, Heidelberg, Victoria, Australia.
Curr Rheumatol Rep. 2021 Apr 28;23(6):36. doi: 10.1007/s11926-021-01003-z.
This review examines axial spondyloarthritis (axSpA) and the wider field of rheumatology through a value-based healthcare (VBHC) lens. VBHC is focused on ensuring patients receive high quality care to improve outcomes and reduce unnecessary costs.
There are many opportunities to apply the principles of VBHC in axSpA. These include the appropriate utilization of diagnostic investigations, such as HLA-B27 and magnetic resonance imaging, assessing outcomes meaningful to patients, and optimizing care pathways. Multidisciplinary care may improve value, and reduced specialist review and medication tapering may be appropriate. Increasing the value of the care we provide to patients can occur across domains and directly and indirectly improves patient outcomes. Taking the time to integrate principles of VBHC into our practice will allow us to justifiably gain and maintain access to diagnostic and therapeutic advances for the benefit of all our patients.
本综述通过价值为基础的医疗保健 (VBHC) 视角来探讨轴性脊柱关节炎 (axSpA) 和更广泛的风湿病领域。VBHC 专注于确保患者获得高质量的护理，以改善结果并降低不必要的成本。
在 axSpA 中，有许多机会可以应用 VBHC 的原则。这些包括适当利用诊断性检查，如 HLA-B27 和磁共振成像，评估对患者有意义的结果，并优化护理路径。多学科护理可能会提高价值，减少专家审查和药物逐渐减少可能是合适的。在各个领域增加我们为患者提供的护理的价值可以直接和间接地改善患者的预后。花时间将 VBHC 的原则整合到我们的实践中，将使我们能够合理地获得和保持对诊断和治疗进展的访问，使我们所有的患者受益。
